Trial · NCT00903331
Adverse events200
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 200
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | DYSPNOEA | Respiratory, thoracic and mediastinal disorders | Placebo | 9 | 59 | |
| other | DYSPNOEA | Respiratory, thoracic and mediastinal disorders | ACT-064922 | 24 | 119 | |
| other | COUGH | Respiratory, thoracic and mediastinal disorders | Placebo | 21 | 59 | |
| other | COUGH | Respiratory, thoracic and mediastinal disorders | ACT-064922 | 22 | 119 | |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Placebo | 12 | 59 | |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | ACT-064922 | 20 | 119 | |
| other | IDIOPATHIC PULMONARY FIBROSIS | Respiratory, thoracic and mediastinal disorders | Placebo | 10 | 59 | |
| other | IDIOPATHIC PULMONARY FIBROSIS | Respiratory, thoracic and mediastinal disorders | ACT-064922 | 17 | 119 | |
| other | BRONCHITIS | Infections and infestations | Placebo | 9 | 59 | |
| other | BRONCHITIS | Infections and infestations | ACT-064922 | 16 | 119 | |
| other | OEDEMA PERIPHERAL | General disorders | Placebo | 4 | 59 | |
| other | OEDEMA PERIPHERAL | General disorders | ACT-064922 | 14 | 119 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Placebo | 0 | 59 | |
| other | ANAEMIA | Blood and lymphatic system disorders | ACT-064922 | 13 | 119 | |
| other | DIZZINESS | Nervous system disorders | Placebo | 5 | 59 | |
| other | DIZZINESS | Nervous system disorders | ACT-064922 | 11 | 119 | |
| other | PULMONARY FUNCTION TEST DECREASED | Investigations | Placebo | 5 | 59 | |
| other | PULMONARY FUNCTION TEST DECREASED | Investigations | ACT-064922 | 9 | 119 | |
| other | ALANINE AMINOTRANSFERASE INCREASED | Investigations | Placebo | 4 | 59 | |
| other | ALANINE AMINOTRANSFERASE INCREASED | Investigations | ACT-064922 | 9 | 119 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00903331/events